Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HAIN CELESTIAL GROUP INCHAIN · Entity 7055 | Director | October 30, 2025 | November 03, 2025 |
| Prestige Consumer Healthcare Inc.PBH · Entity 4350 | Director | August 04, 2026 | August 05, 2026 |
| Purple Innovation, Inc.PRPL · Entity 7764 | Director | April 27, 2023 | May 01, 2023 |
| Spirit Aviation Holdings, Inc.SAVE · Entity 77286 | Director | January 24, 2024 | January 26, 2024 |
| TIVITY HEALTH, INC.TVTY · Entity 125776 | Director · President and COO | October 15, 2019 | October 24, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HAIN CELESTIAL GROUP INC
Report date October 30, 2025 · Filed November 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 402,958 |
Reported balance
After 2025-10-30 transaction · row 1
1 source rowRow 1 · 2025-10-30 · Grant · Acquired 114,729 · Balance 402,958 F1: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 30, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 30, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.
Prestige Consumer Healthcare Inc.
Report date August 04, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 19,514 |
Reported balance
After 2026-08-04 transaction · row 1
1 source rowRow 1 · 2026-08-04 · Grant · Acquired 2,981 · Balance 19,514 F1: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.
Purple Innovation, Inc.
Report date April 27, 2023 · Filed May 01, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Proportional Representation Preferred Linked StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-04-27 transaction · row 1
1 source rowRow 1 · 2023-04-27 · Other · Disposed 423.89 · Balance 0 F1: The Proportional Representation Preferred Linked Stock was originally issued in a stock dividend to all holders of the issuer's Class A common stock and Class B common stock on February 24, 2023. The shares of Proportional Representation Preferred Linked Stock were redeemed by the issuer in accordance with their terms on April 27, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The Proportional Representation Preferred Linked Stock was originally issued in a stock dividend to all holders of the issuer's Class A common stock and Class B common stock on February 24, 2023. The shares of Proportional Representation Preferred Linked Stock were redeemed by the issuer in accordance with their terms on April 27, 2023.
Spirit Aviation Holdings, Inc.
Report date January 24, 2024 · Filed January 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,702 |
Reported balance
After 2024-01-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-01-24 · Grant · Acquired 16,901 · Balance 44,702 F1: Grant of restricted stock units, vesting 100% on January 24, 2025. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units, vesting 100% on January 24, 2025.
F2: Includes restricted stock units.
TIVITY HEALTH, INC.
Report date October 15, 2019 · Filed October 24, 2019 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 641,158 |
Reported balance
After 2019-10-15 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2019-10-15 · Tax withholding · Disposed 88,301 · Balance 641,158 F1: Reflects 88,301 shares withheld to cover the payment of taxes following the distribution of the following awards by the Issuer in connection with the Issuer's acquisition of Nutrisystem, Inc. on March 8, 2019: (i) 84,869 shares of restricted stock and (ii) 118,211 restricted stock units. F2: Reflects a decrease of 104,340 shares previously reported as withheld to cover the payment of taxes on the original Form 4 filed on October 17, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects 88,301 shares withheld to cover the payment of taxes following the distribution of the following awards by the Issuer in connection with the Issuer's acquisition of Nutrisystem, Inc. on March 8, 2019: (i) 84,869 shares of restricted stock and (ii) 118,211 restricted stock units.
F2: Reflects a decrease of 104,340 shares previously reported as withheld to cover the payment of taxes on the original Form 4 filed on October 17, 2019.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NUTRI SYSTEM INC /DE/
Report date March 08, 2019 · Filed March 11, 2019
Section 16 reporting ended · disclosed 2019-03-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2019-03-08 · Disposition to issuer · Disposed 500,140 · Balance 0 F1: This amount includes 41,440 shares of Issuer Common Stock subject to restricted stock awards that, subject to the terms of the Issuer's Amended and Restated 2008 Long-Term Incentive Plan, as amended (the "Plan") and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F2: This amount includes 68,376 shares of Issuer Common Stock subject to PRSUs that, subject to the terms of the Plan and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 20,043 |
Reported balance
After 2019-03-08 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2019-03-08 · Grant · Acquired 20,043 · Balance 20,043 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Common StockSEC Table I · non-derivative | Direct | 12,665 |
Reported balance
After 2019-03-08 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2019-03-08 · Grant · Acquired 12,665 · Balance 12,665 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Common StockSEC Table I · non-derivative | Direct | 20,864 |
Reported balance
After 2019-03-08 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2019-03-08 · Grant · Acquired 20,864 · Balance 20,864 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Common StockSEC Table I · non-derivative | Direct | 57,720 |
Reported balance
After 2019-03-08 transaction · row 5
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 5 · 2019-03-08 · Grant · Acquired 57,720 · Balance 57,720 F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. |
| Common StockSEC Table I · non-derivative | Direct | 90,132 |
Reported balance
After 2019-03-08 transaction · row 6
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 6 · 2019-03-08 · Grant · Acquired 90,132 · Balance 90,132 F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $14.95 · Expires 2021-03-20 | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-08 · Disposition to issuer · Disposed 20,043 · Balance 0 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $21.64 · Expires 2022-12-31 | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-03-08 · Disposition to issuer · Disposed 12,665 · Balance 0 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $20.94 · Expires 2023-01-04 | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-03-08 · Disposition to issuer · Disposed 20,864 · Balance 0 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2019-03-08 · Disposition to issuer · Disposed 57,720 · Balance 0 F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. |
| Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2019-03-08 · Disposition to issuer · Disposed 90,132 · Balance 0 F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This amount includes 41,440 shares of Issuer Common Stock subject to restricted stock awards that, subject to the terms of the Issuer's Amended and Restated 2008 Long-Term Incentive Plan, as amended (the "Plan") and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4.
F2: This amount includes 68,376 shares of Issuer Common Stock subject to PRSUs that, subject to the terms of the Plan and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4.
F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement);
F4: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock.
F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder.
F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value.
F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder.
F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2026 Filed Aug 5, 2026 20:08 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-091086 · tm2622318-5_4seq1.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,514 F1 · shares: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 21:08 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantCommon Stock | 114,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-262554 · ownership.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,958 F1 · shares: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 30, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| August 05, 2025 Filed Aug 6, 2025 20:04 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-074707 · tm2522759-5_4seq1.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,533 F1 · shares: The Reporting Person received 2,094 restricted stock units equal to $155,000 divided by the closing stock price of $74.04 on August 5, 2025, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document |
| May 09, 2025 Filed May 12, 2025 12:01 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | PurchaseCommon Stock | 200,000 | $1.60 | $320,140.00 |
DisclosureSEC source: 0000950170-25-068592 · ownership.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,229 F1 · price: The transaction was executed in multiple trades at prices ranging from $1.55 to $1.64. The price reported reflects the weighted average purchase price. The reporting person undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 21:16 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantCommon Stock | 19,474 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-120715 · ownership.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,229 F1 · shares: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 31, 2025 or the date of the Issuer's 2025 annual meeting of shareholders. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:05 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-086754 · tm2421115-7_4seq1.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,439 F1 · shares: The Reporting Person received 2,202 restricted stock units equal to $150,000 divided by the closing stock price of $68.13 on August 6, 2024, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 21:18 UTC | Spirit Aviation Holdings, Inc. SAVE · Entity 77286 | GrantCommon Stock | 16,901 | $7.10 | $119,997.10 |
DisclosureSEC source: 0001498710-24-000068 · wk-form4_1706303916.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,702 F1 · kind: Grant of restricted stock units, vesting 100% on January 24, 2025. F2 · balance_after: Includes restricted stock units. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:30 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | PurchaseCommon Stock | 5,000 | $11.25 | $56,250.00 |
DisclosureSEC source: 0000910406-23-000120 · wk-form4_1700170212.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,755 Read SEC document |
| October 26, 2023 Filed Oct 30, 2023 21:05 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantCommon Stock | 15,098 | $0.00 | $0.00 |
DisclosureSEC source: 0000910406-23-000105 · wk-form4_1698699911.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,755 F1 · shares: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 26, 2024 or the date of the Issuer's 2024 annual meeting of shareholders. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 18:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-087192 · tm2322776-6_4seq1.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,237 F1 · shares: The Reporting Person received 2,295 restricted stock units equal to $150,000 divided by the closing stock price of $65.37 on August 1, 2023, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. Read SEC document |
| April 27, 2023 Filed May 1, 2023 20:01 UTC | Purple Innovation, Inc. PRPL · Entity 7764 | OtherProportional Representation Preferred Linked Stock | 423.89 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-23-034598 · ownership.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The Proportional Representation Preferred Linked Stock was originally issued in a stock dividend to all holders of the issuer's Class A common stock and Class B common stock on February 24, 2023. The shares of Proportional Representation Preferred Linked Stock were redeemed by the issuer in accordance with their terms on April 27, 2023. F1 · price: The Proportional Representation Preferred Linked Stock was originally issued in a stock dividend to all holders of the issuer's Class A common stock and Class B common stock on February 24, 2023. The shares of Proportional Representation Preferred Linked Stock were redeemed by the issuer in accordance with their terms on April 27, 2023. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 22:09 UTC | Spirit Aviation Holdings, Inc. SAVE · Entity 77286 | GrantCommon Stock | 6,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001498710-23-000066 · wf-form4_167528936259660.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,801 F1 · kind: Grant of restricted stock units, vesting 100% on January 30, 2024. F2 · balance_after: Includes restricted stock units. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:46 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantCommon Stock | 8,346 | $0.00 | $0.00 |
DisclosureSEC source: 0000910406-22-000095 · wf-form4_166906714808583.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,657 F1 · shares: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of November 17, 2023 or the date of the Issuer's 2023 annual meeting of stockholders. Read SEC document |
| August 02, 2022 Filed Aug 3, 2022 21:18 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-085712 · tm2222537-4_4seq1.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,942 F1 · shares: The Reporting Person received 2,495 restricted stock units (equal to $150,000 divided by the closing stock price of $60.12 on August 2, 2022) in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 23:30 UTC | Purple Innovation, Inc. PRPL · Entity 7764 | GrantClass A Common Stock | 17,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-028369 · ownership.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,389 Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 21:00 UTC | Purple Innovation, Inc. PRPL · Entity 7764 | PurchaseClass A Common Stock | 20,000 | $6.95 | $139,000.00 |
DisclosureSEC source: 0001213900-22-010923 · ownership.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,442 Read SEC document |
| January 13, 2022 Filed Jan 18, 2022 21:23 UTC | Spirit Aviation Holdings, Inc. SAVE · Entity 77286 | GrantCommon Stock | 5,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001498710-22-000040 · wf-form4_164254098316178.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,713 F1 · shares: Grant of restricted stock units, vesting 100% on January 13, 2023. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 20:18 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantCommon Stock | 5,410 | $0.00 | $0.00 |
DisclosureSEC source: 0000910406-21-000051 · wf-form4_163579789625390.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,311 F1 · shares: Represents a grant of restricted stock units as compensation under the Issuer's compensation program for non-employee directors. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The restricted stock units will vest on the earlier of October 28, 2022 or the date of the Issuer's 2022 annual meeting of stockholders. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:00 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-100931 · tm2124298-5_4seq1.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,447 F1 · shares: The Reporting Person received 2,808 restricted stock units (equal to $150,000 divided by the closing stock price of $53.42 on August 3, 2021) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| May 21, 2021 Filed May 26, 2021 00:20 UTC | Purple Innovation, Inc. PRPL · Entity 7764 | GrantClass A Common Stock | 2,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-029177 · ownership.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,442 Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 21:21 UTC | Spirit Aviation Holdings, Inc. SAVE · Entity 77286 | GrantCommon Stock | 4,769 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-003774 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 F1 · shares: Grant of restricted stock units, vesting 100% on January 13, 2022. F2 · balance_after: Includes restricted stock units. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 22:35 UTC | Purple Innovation, Inc. PRPL · Entity 7764 | GrantClass A Common Stock | 1,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-040271 · ownership.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,473 Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 21:17 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000910406-20-000079 · wf-form4_160633903089694.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,901 F1 · shares: Represents a grant of restricted stock units as compensation under the Issuer's compensation program for non-employee directors. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The restricted stock units will vest on the earlier of November 24, 2021 or the date of the Issuer's 2021 annual meeting of stockholders. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 21:21 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 3,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-091542 · tm2023357d2_4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,639 F1 · shares: The Reporting Person received 3,732 restricted stock units (equal to $145,000 divided by the closing stock price of $38.86 on August 4, 2020) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:40 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 907 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-057488 · tm2018844d8_4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 907 F1 · shares: The Reporting Person received a prorated grant of 907 restricted stock units (equal to $145,000 divided by the closing stock price of $39.98 on May 4, 2020). The restricted stock units vest on May 4, 2021. Read SEC document |
| May 04, 2020 Filed May 7, 2020 19:32 UTC Amendment | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 907 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-058054 · tm2019008d1_4a.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 907 F1 · shares: This amendment is being filed to reflect the correct value of the prorated grant of 907 restricted stock units (equal to $36,262 divided by the closing stock price of $39.98 on May 4, 2020). The value was stated incorrectly in this footnote on the original Form 4 filed on May 6, 2020. Read SEC document |
| January 14, 2020 Filed Jan 15, 2020 23:24 UTC | Spirit Aviation Holdings, Inc. SAVE · Entity 77286 | GrantCommon Stock | 3,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001498710-20-000031 · wf-form4_157913065348123.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,898 F1 · kind: Grant of restricted stock units, vesting 100% on January 14, 2021. F2 · balance_after: Includes restricted stock units. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 21:53 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantCommon Stock | 9,555 | $0.00 | $0.00 |
DisclosureSEC source: 0000910406-19-000129 · wf-form4_157437321625613.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,401 F1 · shares: Represents a restricted stock award received as compensation under the Issuer's compensation program for non-employee directors. The award will vest on the earlier of November 19, 2020 or the date of the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 16:40 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | Tax withholdingCommon Stock | 192,641 | $15.90 | $3,062,991.90 |
DisclosureSEC source: 0001567619-19-019692 · doc1.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,818 F1 · shares: Reflects 192,641 shares withheld to cover the payment of taxes following the distribution of the following awards that were assumed by the Issuer in connection with the Issuer's acquisition of Nutrisystem, Inc. on March 8, 2019: (i) 84,869 shares of restricted stock and (ii) 358,181 restricted stock units. Read SEC document |
| October 15, 2019 Filed Oct 24, 2019 14:33 UTC Amendment | TIVITY HEALTH, INC. TVTY · Entity 125776 | Tax withholdingCommon Stock | 88,301 | $15.90 | $1,403,985.90 |
DisclosureSEC source: 0001567619-19-019964 · doc1.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641,158 F1 · shares: Reflects 88,301 shares withheld to cover the payment of taxes following the distribution of the following awards by the Issuer in connection with the Issuer's acquisition of Nutrisystem, Inc. on March 8, 2019: (i) 84,869 shares of restricted stock and (ii) 118,211 restricted stock units. F2 · shares: Reflects a decrease of 104,340 shares previously reported as withheld to cover the payment of taxes on the original Form 4 filed on October 17, 2019. Read SEC document |
| April 11, 2019 Filed May 7, 2019 18:13 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 58,325 | $20.36 | $1,187,497.00 |
DisclosureSEC source: 0001567619-19-010060 · doc1.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729,459 F1 · shares: Reflects the annual grant of restricted stock units. Restricted stock units vest 33% on 4/11/2020, 33% on 4/11/2021, and 34% on 4/11/2022. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 14:58 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Disposition to issuerPerformance-Based Restricted Stock Units · Derivative | 90,132 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018377 · doc4.xml · derivative · entry 11 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,132 shares Expires not disclosed F8 · derivative.exercise_price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7 · kind: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F3 · derivative.exercise_date: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4 · derivative.exercise_date: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. F3 · derivative.expiration_date: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4 · derivative.expiration_date: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 14:58 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Disposition to issuerPerformance-Based Restricted Stock Units · Derivative | 57,720 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018377 · doc4.xml · derivative · entry 10 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,720 shares Expires not disclosed F8 · derivative.exercise_price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7 · kind: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F3 · derivative.exercise_date: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4 · derivative.exercise_date: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. F3 · derivative.expiration_date: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4 · derivative.expiration_date: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 14:58 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Disposition to issuerOption to Purchase Common Stock · Derivative | 20,864 | Not disclosed Strike: $20.94 | Not disclosed |
DisclosureSEC source: 0001209191-19-018377 · doc4.xml · derivative · entry 9 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,864 shares Expires 2023-01-04 F5 · kind: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 14:58 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Disposition to issuerOption to Purchase Common Stock · Derivative | 12,665 | Not disclosed Strike: $21.64 | Not disclosed |
DisclosureSEC source: 0001209191-19-018377 · doc4.xml · derivative · entry 8 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,665 shares Expires 2022-12-31 F5 · kind: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 14:58 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Disposition to issuerOption to Purchase Common Stock · Derivative | 20,043 | Not disclosed Strike: $14.95 | Not disclosed |
DisclosureSEC source: 0001209191-19-018377 · doc4.xml · derivative · entry 7 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,043 shares Expires 2021-03-20 F5 · kind: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 14:58 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon Stock | 90,132 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018377 · doc4.xml · nonDerivative · entry 6 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,132 F7 · price: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 14:58 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon Stock | 57,720 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018377 · doc4.xml · nonDerivative · entry 5 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,720 F7 · price: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 14:58 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon Stock | 20,864 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018377 · doc4.xml · nonDerivative · entry 4 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,864 F5 · price: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 14:58 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon Stock | 12,665 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018377 · doc4.xml · nonDerivative · entry 3 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,665 F5 · price: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 14:58 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon Stock | 20,043 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018377 · doc4.xml · nonDerivative · entry 2 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,043 F5 · price: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6 · price: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 14:58 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Disposition to issuerCommon Stock | 500,140 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018377 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: This amount includes 41,440 shares of Issuer Common Stock subject to restricted stock awards that, subject to the terms of the Issuer's Amended and Restated 2008 Long-Term Incentive Plan, as amended (the "Plan") and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F2 · shares: This amount includes 68,376 shares of Issuer Common Stock subject to PRSUs that, subject to the terms of the Plan and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F3 · price: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4 · price: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 19:03 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 630,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-006744 · doc1.xml · nonDerivative · entry 2 ZIER DAWN M. · CIK 0001562083 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 706,115 F2 · shares: Reflects (A) the following awards that were assumed by the Issuer in connection with the Merger: (i) an award of 84,869 shares of restricted stock that vest in full on October 15, 2019; (ii) an award of 118,211 restricted stock units that vest in full on October 15, 2019; (iii) an award of 140,034 restricted stock units that vest on a pro-rata daily basis, beginning on and following October 15, 2019 through December 31, 2019, with such pro-rata daily vesting dating back to February 15, 2017; and (iv) an award of 184,590 restricted stock units that vest on a pro-rata daily basis, beginning on and following October 15, 2019 through December 31, 2020, with such pro-rata daily vesting dating back to January 2, 2018; and (B) an award of 102,987 restricted stock units that vest in full on May 31, 2020, that was issued under the Issuer's Amended and Restated 2014 Stock Incentive Plan. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 19:03 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 75,424 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-006744 · doc1.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,424 F1 · price: Received in exchange for 352,288 shares of common stock of Nutrisystem, Inc. ("Nutrisystem") in connection with the merger (the "Merger") of Nutrisystem with and into Sweet Acquisition, Inc. ("Merger Sub"), pursuant to that certain Agreement and Plan of Merger, dated December 9, 2018, by and between the Issuer, Merger Sub and Nutrisystem. On March 7, 2019, the last day on which Nutrisystem's common stock was publicly traded, the closing price of Nutrisystem common stock was $42.89 per share, and on March 8, 2019, the date of the effective time of the Merger, the closing price of the Issuer's common stock was $19.42 per share. Read SEC document |
| March 08, 2019 Filed Apr 12, 2019 14:23 UTC Amendment | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 40,443 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-008740 · doc1.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671,134 F2 · shares: Reflects a decrease of 34,981 shares previously reported as owned by the Reporting Person on the original Form 4 filed on March 12, 2019. F1 · price: Received in exchange for 188,900 shares of common stock of Nutrisystem, Inc. ("Nutrisystem") in connection with the merger (the "Merger") of Nutrisystem with and into Sweet Acquisition, Inc. ("Merger Sub"), pursuant to that certain Agreement and Plan of Merger, dated December 9, 2018, by and between the Issuer, Merger Sub and Nutrisystem. On March 7, 2019, the last day on which Nutrisystem's common stock was publicly traded, the closing price of Nutrisystem common stock was $42.89 per share, and on March 8, 2019, the date of the effective time of the Merger, the closing price of the Issuer's common stock was $19.42 per share. F2 · balance_after: Reflects a decrease of 34,981 shares previously reported as owned by the Reporting Person on the original Form 4 filed on March 12, 2019. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 08:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon stock | 68,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-010872 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,716 F1 · security: Restricted stock units were granted upon the achievement of certain specified performance goals and will vest, subject to continued employment, on December 31, 2019. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 22:13 UTC | Spirit Aviation Holdings, Inc. SAVE · Entity 77286 | GrantCommon Stock | 1,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-003761 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,883 F1 · shares: Grant of restricted stock units, vesting on January 11, 2020. F2 · balance_after: Includes restricted stock units. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 22:03 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantCommon Stock | 13,360 | $17.44 | $232,998.40 |
DisclosureSEC source: 0000910406-19-000018 · wf-form4_154707141161811.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,846 F1 · shares: Represents a grant of restricted shares of the Issuer's common stock, which will vest on October 29, 2019. Read SEC document |
| January 04, 2019 Filed Jan 7, 2019 16:05 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 2,595 | $43.98 | $114,128.10 |
DisclosureSEC source: 0001209191-19-002488 · doc4.xml · nonDerivative · entry 2 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,340 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 16:05 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 3,758 | $43.45 | $163,285.10 |
DisclosureSEC source: 0001209191-19-002488 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,935 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.